CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Total	Series B1 Preferred Stock	Series B Preferred Stock	Common Stock	Common Stock Series A Preferred	Common Stock Series B1 Preferred Stock	Common Stock Series B Preferred Stock	Preferred Stock Series A Preferred	Preferred Stock Series C Preferred	Additional Paid-in Capital	Additional Paid-in Capital Series B1 Preferred Stock	Additional Paid-in Capital Series B Preferred Stock	Accumulated Deficit	Accumulated Deficit Series B Preferred Stock	Non-controlling Interest
Balance at beginning (in shares) at Dec. 31, 2019				43,396,000				420,000	0
Balance at beginning at Dec. 31, 2019	$ 23,102,000			$ 44,000				$ 0	$ 0	$ 81,528,000			$ (59,247,000)		$ 777,000
Increase (Decrease) in Stockholders' Equity
Dividends on Series B and B1 Preferred Stock	(1,903,000)												(1,903,000)
Accretion of discount on Series B and B1 Preferred Stock	(1,688,000)												(1,688,000)
Purchase of shares of consolidated subsidiary	(71,000)									(71,000)
Share based compensation expense	656,000									656,000
Adjustment of carrying amount of noncontrolling interest	$ 9,091,000									9,091,000
Exercise of options to common (in shares)	0
Conversion of Series B1 Preferred stock to common stock (in shares)				2,159,000
Conversion of Series B1 Preferred stock to common	$ 3,368,000			$ 2,000						3,366,000
Adjustment of redeemable noncontrolling interest to redemption value	(15,135,000)												(15,135,000)
Net income (loss)	(11,396,000)												(12,036,000)		640,000
Less: amount attributable to redeemable non-controlling interest	(99,000)														(99,000)
Balance at end (in shares) at Dec. 31, 2020				45,555,000				420,000	0
Balance at end at Dec. 31, 2020	5,925,000			$ 46,000				$ 0	$ 0	94,570,000			(90,009,000)		1,318,000
Increase (Decrease) in Stockholders' Equity
Dividends on Series B and B1 Preferred Stock	(372,000)												(372,000)
Accretion of discount on Series B and B1 Preferred Stock	(507,000)												(507,000)
Share based compensation expense	$ 863,000									863,000
Exercise of options to common (in shares)	2,042,000			1,800,000		3,093,000
Exercise of options to common	$ 2,190,000	$ 16,405,000		$ 2,000		$ 3,000				2,188,000	$ 16,402,000
Distribution to noncontrolling	(169,000)														(169,000)
Conversion of Series B1 Preferred stock to common stock (in shares)				7,722,000
Conversion of Series B1 Preferred stock to common	12,045,000			$ 7,000						12,038,000
Conversion of Series A Preferred stock to common stock (in shares)				34,000				(34,000)
Adjustment of redeemable noncontrolling interest to redemption value	(1,992,000)												(1,992,000)
Conversion of Series B Preferred Stock to common stock (in shares)							5,084,000
Conversion of Series B Preferred Stock to common stock			$ 13,194,000				$ 5,000					$ 12,559,000		$ 630,000
Contribution from noncontrolling interest	(11,000)														(11,000)
Net income (loss)	(7,661,000)												(18,364,000)		10,703,000
Less: amount attributable to redeemable non-controlling interest	(9,844,000)														(9,844,000)
Balance at end (in shares) at Dec. 31, 2021				63,288,000				386,000	0
Balance at end at Dec. 31, 2021	30,066,000			$ 63,000				$ 0	$ 0	138,620,000			(110,614,000)		1,997,000
Increase (Decrease) in Stockholders' Equity
Purchase of shares of consolidated subsidiary	41,000														41,000
Share based compensation expense	1,574,000									1,574,000
Reclass of derivative liabilities	$ 78,789,000									78,789,000
Exercise of options to common (in shares)	653,000			622,000		1,209,000
Exercise of options to common	$ 730,000	$ 0		$ 1,000		$ 1,000				729,000	$ (1,000)
Adjustment of redeemable non controlling interest	0									29,000			(29,000)
Distribution to noncontrolling	(380,000)														(380,000)
Conversion of Series A Preferred stock to common stock (in shares)					386,000			(386,000)
Conversion of Series A Preferred stock to common stock	1,000				$ 1,000
Conversion of Convertible Senior Notes to common (net of tax) (in shares)				10,165,000
Conversion of Convertible Senior Notes to common, net	59,822,000			$ 10,000						59,812,000
Adjustment of redeemable noncontrolling interest to redemption value	(428,000)												(428,000)
Net income (loss)	1,997,000												(4,822,000)		6,819,000
Less: amount attributable to redeemable non-controlling interest	(6,792,000)														(6,792,000)
Balance at end (in shares) at Dec. 31, 2022				75,670,000				0	0
Balance at end at Dec. 31, 2022	$ 165,420,000			$ 76,000				$ 0	$ 0	$ 279,552,000			$ (115,893,000)		$ 1,685,000